Abstract
Since 2011, the European guidelines have included a specific low-density lipoprotein cholesterol (LDL-C) target, <70 mg/dl, for very high cardiovascular risk (CVR) patients. However, registries have shown unsatisfactory results in obtaining this level of adequate lipid control. To assess temporal trends in the use of lipid-lowering therapy (LLT) and attainment of adequate control in very high CVR patients since 2011. We performed a retrospective observational study including very high CVR patients admitted in two periods: the first two years since the 2011 guidelines (2011/2012) and five years later (2016/2017). Lipid values, LLT, clinical variables and adequate lipid control rates were analyzed. A total of 1314 patients were reviewed (2011/2012: 638; 2016/2017: 676). Overall, 443 patients (33.7%) were not under LLT and only a slight improvement in drug prescription was observed from 2011/2012 to 2016/2017. In LLT users, the proportion of high-intensity LLT increased significantly in the later years (6.4% vs. 24.0%; p<0.001), but this was not associated with adequate lipid control. Overall, mean LDL-C was 95.4±37.2 mg/dl and adequate control was achieved in 320 patients (24.4%), without significant differences between 2011/2012...Continue Reading
References
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Sep 26, 2003·European Journal of Clinical Pharmacology·Iosief AbrahaCarlo Romagnoli
Oct 11, 2005·Lancet·C BaigentUNKNOWN Cholesterol Treatment Trialists' (CTT) Collaborators
Feb 13, 2007·The American Journal of Cardiology·Sachin J Kamal-BahlChuck Wentworth
Sep 24, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Marie-Therese CooneyUNKNOWN SCORE Investigators
Jun 30, 2011·European Heart Journal·UNKNOWN European Association for Cardiovascular Prevention & RehabilitationUNKNOWN ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees
Feb 1, 2012·Circulation·Kiang LiuDonald M Lloyd-Jones
Feb 18, 2015·European Journal of Preventive Cardiology·Kornelia KotsevaUNKNOWN on behalf of the EUROASPIRE Investigators
Mar 17, 2015·The New England Journal of Medicine·Jennifer G RobinsonUNKNOWN ODYSSEY LONG TERM Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc S SabatineUNKNOWN Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
May 26, 2016·European Heart Journal·Massimo F PiepoliUNKNOWN ESC Scientific Document Group
Aug 28, 2016·European Heart Journal·Alberico L CatapanoUNKNOWN ESC Scientific Document Group
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
May 18, 2018·European Journal of Preventive Cardiology·Nicolas DanchinUNKNOWN ICLPS Investigators
Nov 8, 2018·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN ODYSSEY OUTCOMES Committees and Investigators
Jan 9, 2019·Journal of the American Heart Association·Lisandro D ColantonioPaul Muntner
Feb 14, 2019·JAMA Cardiology·Fatima RodriguezPaul A Heidenreich
Nov 11, 2019·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Pedro Marques da SilvaUNKNOWN DISGEN-LIPID study Investigators